{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Bimatoprost+Ophthalmic", "query": { "intervention": "Bimatoprost Ophthalmic" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 76, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Bimatoprost+Ophthalmic&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-25T08:25:59.194Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02358369", "title": "Dose-Ranging Study of the Bimatoprost Ocular Insert", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Primary Open-Angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost", "type": "DRUG" }, { "name": "Timolol 0.5%", "type": "DRUG" }, { "name": "Placebo Ocular Insert", "type": "DEVICE" }, { "name": "Placebo Eye Drops", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "ForSight Vision5, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 156, "start_date": "2015-01-19", "completion_date": "2015-10-07", "has_results": true, "last_update_posted_date": "2020-06-04", "last_synced_at": "2026-09-25T08:25:59.194Z", "location_count": 10, "location_summary": "Fayetteville, Arkansas • Artesia, California • Newport Beach, California + 7 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Artesia", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Morrow", "state": "Georgia" }, { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02358369" }, { "nct_id": "NCT04285580", "title": "A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Open-Angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost SR", "type": "DRUG" }, { "name": "LUMIGAN", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 37, "start_date": "2020-06-11", "completion_date": "2022-05-14", "has_results": true, "last_update_posted_date": "2023-06-08", "last_synced_at": "2026-09-25T08:25:59.194Z", "location_count": 6, "location_summary": "Dothan, Alabama • Newport Beach, California • Roswell, Georgia + 3 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Newport Beach", "state": "California" }, { "city": "Roswell", "state": "Georgia" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Cranberry Township", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04285580" }, { "nct_id": "NCT07218796", "title": "Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cataract", "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost Implant System", "type": "DRUG" }, { "name": "SpyGlass IOL", "type": "DEVICE" }, { "name": "Timolol Maleate Ophthalmic Solution, 0.5%", "type": "DRUG" }, { "name": "Commercial IOL", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "SpyGlass Pharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 400, "start_date": "2025-10-28", "completion_date": "2031-05-31", "has_results": false, "last_update_posted_date": "2025-10-20", "last_synced_at": "2026-09-25T08:25:59.194Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07218796" }, { "nct_id": "NCT00693420", "title": "Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Eyelashes" ], "interventions": [ { "name": "Bimatoprost 0.03% sterile solution", "type": "DRUG" }, { "name": "vehicle sterile solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 278, "start_date": "2007-04", "completion_date": "2007-12", "has_results": true, "last_update_posted_date": "2013-10-30", "last_synced_at": "2026-09-25T08:25:59.194Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00693420" }, { "nct_id": "NCT01830140", "title": "A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost 0.01%", "type": "DRUG" }, { "name": "Bimatoprost 0.03%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 466, "start_date": "2013-07", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2015-05-06", "last_synced_at": "2026-09-25T08:25:59.194Z", "location_count": 2, "location_summary": "Artesia, California • El Paso, Texas", "locations": [ { "city": "Artesia", "state": "California" }, { "city": "El Paso", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01830140" }, { "nct_id": "NCT00907426", "title": "Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypotrichosis" ], "interventions": [ { "name": "Bimatoprost 0.03% solution", "type": "DRUG" }, { "name": "Vehicle solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 368, "start_date": "2009-08", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2012-09-19", "last_synced_at": "2026-09-25T08:25:59.194Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00907426" }, { "nct_id": "NCT02097719", "title": "Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "bimatoprost 0.01%", "type": "DRUG" }, { "name": "travoprost 0.004%", "type": "DRUG" }, { "name": "timolol 0.5%", "type": "DRUG" }, { "name": "hypromellose 0.3%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2014-05", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2016-01-14", "last_synced_at": "2026-09-25T08:25:59.194Z", "location_count": 1, "location_summary": "Racine, Wisconsin", "locations": [ { "city": "Racine", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT02097719" }, { "nct_id": "NCT05335122", "title": "A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Open Angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "OTX-TIC low dose Travoprost Intracameral Implant", "type": "DRUG" }, { "name": "OTX-TIC high dose Travoprost Intracameral Implant", "type": "DRUG" }, { "name": "Durysta, Bimatoprost Intracameral Implant 10 µg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ocular Therapeutix, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 83, "start_date": "2022-03-16", "completion_date": "2025-01-24", "has_results": true, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-09-25T08:25:59.194Z", "location_count": 30, "location_summary": "Dothan, Alabama • Huntington Beach, California • Irvine, California + 27 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05335122" }, { "nct_id": "NCT00809848", "title": "Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Ocular Hypertension", "Glaucoma" ], "interventions": [ { "name": "AGN-210669 ophthalmic solution, 0.075%", "type": "DRUG" }, { "name": "AGN-210669 ophthalmic solution, 0.05%", "type": "DRUG" }, { "name": "AGN-210669 ophthalmic solution, 0.025%", "type": "DRUG" }, { "name": "bimatoprost ophthalmic solution 0.03%", "type": "DRUG" }, { "name": "AGN-210669 vehicle ophthalmic solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 172, "start_date": "2009-02", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2013-10-18", "last_synced_at": "2026-09-25T08:25:59.194Z", "location_count": 1, "location_summary": "Artesia, California", "locations": [ { "city": "Artesia", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00809848" }, { "nct_id": "NCT04499248", "title": "AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Open-angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "AGN-193408 SR", "type": "DRUG" }, { "name": "Lumigan", "type": "OTHER" }, { "name": "Sham Administration", "type": "OTHER" }, { "name": "Lumigan Vehicle", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2020-11-16", "completion_date": "2029-04", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-09-25T08:25:59.194Z", "location_count": 42, "location_summary": "Sun City, Arizona • Glendale, California • Inglewood, California + 38 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Glendale", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04499248" } ] }